DCT

2:20-cv-02545

Boehringer Ingelheim Pharma Inc v. HEC Pharm Co Ltd

General

Filed

05/29/20

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (06/01/20)

Patent Owner

NPE (W)

PACER

Nature of Suit835 ANDA

Judge	Period	PO Win Rate
Wendy Beetlestone	06/24/20 - 03/03/21	--

Plaintiff

Party

Name	Ratings
Boehringer-Ingelheim Pharmaceuticals Inc NPE	L4 A
Boehringer-Ingelheim Pharma GmbH NPE	L4 A
Boehringer Ingelheim Pharma GmbH NPE	L4 A
Boehringer-Ingelheim Corp NPE	L4 A
Boehringer Ingelheim Corp NPE	L4 A
Boehringer Ingelheim Intl GmbH	L4 A

No Parties

Attorney

Name	Ratings
Kirkland & Ellis LLP	L5 B
James F. Hurst	L5 E
Bryan S. Hales	L4 A
Jeanna Wacker	L3 E
Mira A. Mulvaney	L2 E
Sam Kwon	-- -- --
Walsh Pizzi Oreilly Falanga LLPLocal	L3 B
Peter J. Pizzi	-- -- --

No Attorneys

Defendant

Party

Name	Ratings
HEC Pharm Co Ltd	L1 E
HEC Pharm USA Inc	L1 E

No Parties

Attorney

No Attorneys